Stay updated on Pembrolizumab with Radium-223 in mCRPC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with Radium-223 in mCRPC Clinical Trial page.

Latest updates to the Pembrolizumab with Radium-223 in mCRPC Clinical Trial page
- Check3 days agoChange DetectedAdded related topics sections for Prostate cancer and MedlinePlus Genetics.SummaryDifference0.2%

- Check11 days agoChange DetectedFooter revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedThe page shows a minor version update label from v3.4.1 to v3.4.2; no substantive study content or functionality changes are observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check40 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1; no substantive changes to the study content are shown. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check54 days agoChange DetectedAdded related topics: Prostate cancer and MedlinePlus Genetics to provide additional navigation context; these are minor navigational enhancements that do not affect the study details, and To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check61 days agoChange DetectedThe page shows a new Revision: v3.3.4 tag, and the old Revision: v3.3.3 tag is removed.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab with Radium-223 in mCRPC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Radium-223 in mCRPC Clinical Trial page.